7-Cyano-8-Hydroxyquinoline Derivatives for Stronger Antibacterial Activity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current quinoline derivatives exhibit limited antibacterial and antitumor activity, necessitating the development of more effective compounds for treating infectious diseases and tumors.
Innovation Solution
Synthesis of 7-cyano-8-hydroxyquinoline derivatives with specific substituents (R1 to R5) to enhance antibacterial and antitumor activity, including dealkylation and halogenation reactions to form compounds of formula (I) and (II).
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current quinoline derivatives are used, then they have a relatively safe history of use, but their antibacterial and antitumor activity is limited
Solution Approach 1:
The patent introduces specific substituent groups (R1-R5) at different positions of the quinoline core structure, where each substituent can be independently selected from specific chemical groups (halogen, alkyl, hydroxy, etc.). This local modification approach allows optimization of specific properties (antibacterial/antitumor activity) while maintaining the overall safety profile of the quinoline scaffold.
Solution Approach 2:
The patent systematically varies multiple parameters including substituent types (halogen, alkyl, hydroxy, etc.), substituent positions (R1-R5), and molecular weight ranges to optimize both activity and safety. The compounds are designed with specific molecular weight ranges (150-300 Da) and LogP values (0.5-3.0) to balance pharmacokinetic properties with therapeutic efficacy.
2Quantity of substance
If 7-cyano-8-hydroxyquinoline derivatives are synthesized with multiple substituent options, then antibacterial and antitumor activity is enhanced, but the complexity of compound design and synthesis increases
Solution Approach 1:
The patent divides the molecule into a core quinoline structure (with fixed 7-cyano-8-hydroxy substitution) and multiple independent substituent positions (R1-R5). Each substituent can be independently selected from predefined groups, allowing systematic optimization without requiring complete redesign of the entire molecule. This segmentation simplifies the synthesis strategy by enabling modular construction.
Solution Approach 2:
The patent creates a universal scaffold (7-cyano-8-hydroxyquinoline) that can serve multiple therapeutic purposes (antibacterial, antitumor, antiviral activities). The same core structure with varying substituents addresses multiple medical needs, reducing the need for separate development programs for different indications.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The synthesized derivatives demonstrate excellent antibacterial and antitumor activity, providing therapeutic options for infections and tumors, particularly against gram-negative bacteria, gram-positive bacteria, viruses, and cancers like bladder and prostate cancer.
Implementation Method 1
subjecting a compound of formula (IA) to a dealkylation reaction in the presence of lithium chloride to form the compound of formula (I)
Implementation Method 2
reacting a compound of formula (IA) with zinc cyanide to form the compound of formula (IA)
Implementation Method 3
reacting a compound of formula (IA) with a halogenating reagent to form the compound of formula (IA)
Data Source
AI summary
Provided are a 7-cyano-8-hydroxyquinoline derivative, a preparation method therefor and a medical use thereof specifically, disclosed are a compound represented by general formula (I), a preparation method therefor, a pharmaceutical composition containing same, and a use thereof in the treatment of infectious diseases or cancer. The compound has excellent antibacterial, antiviral and antitumor activity, and can be developed as a drug for the treatment of infectious diseases or tumors. The definitions of groups in the general formula (I) are the same as in the description.